SUBSCRIBE
SUBSCRIBE

Iowa

Job Trends
BioSpace Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
 · 
2 min read
 · 
Chantal Dresner
Job Trends
BioSpace Showcases Life Sciences Hubs in 2025 Hotbed Maps
BioSpace has revealed its 2025 Hotbed Maps, showcasing nine regional hot spots for life sciences activity.
January 21, 2025
 · 
1 min read
 · 
Chantal Dresner
PRESS RELEASES
Press Releases
Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development
September 16, 2026
 · 
6 min read
Press Releases
Syncromune® Presents SYNC-T™ Therapy: Image-Guided Cryolysis and Intratumoral Immunotherapy at CIRSE 2026
September 9, 2026
 · 
8 min read
Press Releases
Bayer Advances Combined Seed and Crop Protection Pipeline and Enters Phase of Blockbuster Launches
September 2, 2026
 · 
10 min read
Press Releases
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
August 18, 2026
 · 
5 min read
Press Releases
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination
August 11, 2026
 · 
7 min read
Proliant Health & Biologicals Raises the Albumin Standard with AlbufreeDX: Consistent, Animal-Free Recombinant Human Albumin
June 29, 2026
 · 
2 min read
Press Releases
Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium
June 16, 2026
 · 
6 min read
Press Releases
Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Growing Global Demand for MRD Solutions
April 20, 2026
 · 
5 min read
Press Releases
Syncromune Continues to Strengthen Executive and Clinical Leadership with Appointment of Dr. Stephen P. Dale, M.D., as Chief Medical Officer
January 6, 2026
 · 
6 min read
Press Releases
Syncromune®, Inc. Presents Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at Society of Urological Oncology 26th Annual Meeting
December 4, 2025
 · 
7 min read
Press Releases
Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual Meeting
November 21, 2025
 · 
5 min read
Press Releases
Researchers Link Orphan Gene in SARS-CoV-2 Virus to More Severe Cases of COVID-19
October 22, 2025
 · 
4 min read
Press Releases
Integrated DNA Technologies Announces Translational CRISPR Portfolio Expansion with Product Innovation Updates
July 17, 2025
 · 
4 min read
Press Releases
Integrated DNA Technologies Announces Innovation Roadmap Advances to Infectious Disease Portfolio
June 16, 2025
 · 
4 min read
Press Releases
Syncromune® Appoints Industry Veteran Kerri-Ann Millar as Chief Financial Officer to Advance Corporate Growth Initiatives and Clinical Development Program
June 16, 2025
 · 
6 min read
Press Releases
Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025
June 2, 2025
 · 
7 min read
Press Releases
Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
May 30, 2025
 · 
6 min read
Press Releases
Syncromune® Inc. Announces Publication of Abstract on SYNC-T® Therapy SV-102 Phase 1 Data for Metastatic Prostate Cancer at ASCO 2025 Annual Meeting
May 23, 2025
 · 
6 min read
Press Releases
Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy
May 15, 2025
 · 
6 min read
Press Releases
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
April 25, 2025
 · 
5 min read